Symposium 8 Novel therapeutic strategy for AML

[SY8-3] 急性骨髄性白血病に対するHedgehog inhibitorによる効果とバイオマーカーの検討

南 陽介¹, 福島 庸晃², 垣内 誠司³, 南 博信³, 清井 仁², 直江 知樹⁴ (1.国立がん研究センター東病院　血液腫瘍科, 2.名古屋大学大学院　医学系研究科　血液・腫瘍内科学, 3.神戸大学　大学院医学研究科　腫瘍・血液内科学, 4.国立病院機構　名古屋医療センター)

Professional Experience and Education:
1990-1996 Bachelor of M.D., Nagoya University School of Medicine
1996-1999 Resident / Clinical Staff of Department of Hematology, Komaki Municipal Hospital
1999-2003 Ph.D. course, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
2003-2008 Research Associate, Division of Hematology-Oncology, Moores University of California San Diego Cancer Center
2008-2013 Clinical Staff / Lecturer, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
2013-2017 Lecturer, Department of Transfusion Medicine and Cell Therapy, Kobe University Hospital
2017-present Chief, Department of Hematology, National Cancer Center Hospital East
Other activities and Honors (selected):
2007 Scholarship & Plenary Speech, Keystone Symposia
2009 Scholarship & Plenary Speech, Gordon Research Conferences
2015 The 57th ASH annual meeting, program committee member and moderator
present JALSG: CML212 committee vice-PI, STIM213 committee, GML213 committee
present PMDA (Pharmaceuticals and Medical Devise Agency): medical expert adviser